Article Sidebar

PDF
Date Published: 06/01/2022
Abstract Views: 115
Views PDF: 125
DOI: https://doi.org/10.47972/vjcts.v35i.686
Issue
Vol. 35: SỐ ĐẶC BIỆT KỶ NIỆM 20 NĂM THÀNH LẬP BỆNH VIỆN TIM HÀ NỘI
Section
Research Article
How to Cite
Ha, N. C., Long, T. D., & Hung, N. Q. (2022). Transpercutaneous closure of perimembranous ventricular septal defects by symmatric occluder . The Vietnam Journal of Cardiovascular and Thoracic Surgery, 35, 100-106. https://doi.org/10.47972/vjcts.v35i.686

Transpercutaneous closure of perimembranous ventricular septal defects by symmatric occluder

Nguyen Cong Ha, Tran Dac Long, Nguyen Quoc Hung

Main Article Content

Abstract

Background: Ventricular septal defect ( VSD ) is the most frequently occurring congenital cardiac disease, accounts nearly 15-30% of all cases. Surgery is still the corrective therapy with high success and low complication but having some problems with: cardiopulmonary bypass, anesthesia, ICU, sternalitis, chest scar, AV block...


Recently many progress in cardiac intervention applied to treat congenital heart disease especially percutaneous VSD closure. Currently patients with VSD have other choice to cure safely, effectively and less complication.


Objectives: To evaluate 12 months rusults from transpercutaneous closure of perimembranous VSD by modified double – disk symmatric devices ( symmatric occluder).


Methods: This is the descriptive clinical trial and follow-up.


Result: 41 patients selected by echocardiography, 37 patients were closed successfully (90,2% success rate). No significant complication (AVB…) and  1 patient nonsignificant shunt is 2.7% after 12 month follow-up.


Conclusions: Transpercutaneous closure of perimembranous VSD by symmatric occluder is effective and safe and more, longer follow-up.

Article Details

Keywords

transpercutaneous VSD closure, symmatric occluder

References

1. Bu, H., et al., [Application of perimembranous ventricular septal defects closure solely by femoral vein approach under transesophageal echocardiography guidance]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2017. 42(7): p. 802-807.
2. Hijazi, Z.M., et al., Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience. Catheter Cardiovasc Interv, 2002. 56(4): p. 508-15.
3. Bulut, M.O., et al., Treatment of severe hemolysis following Nit-Occlud Le VSD coil implantation with Amplatzer Duct Occluder II. Turk Kardiyol Dern Ars, 2016. 44(7): p. 593-596.
4. Wang, L., et al., Transcatheter closure of congenital perimembranous ventricular septal defect in children using symmetric occluders: an 8-year multiinstitutional experience. Ann Thorac Surg, 2012. 94(2): p. 592-8.
5. Li, P., et al., Arrhythmias after transcatheter closure of perimembranous ventricular septal defects with a modified double-disk occluder: early and long-term results. Heart Vessels, 2012. 27(4): p. 405-10.
6. Predescu, D., et al., Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg, 2008. 136(5): p. 1223-8.
7. Liu, J., et al., Outcome of transcatheter closure of perimembranous ventricular septal defect with modified double-disk occluder device. Zhonghua Xin Xue Guan Bing Za Zhi, 2010. 38(4): p. 321-5.
8. Ghosh, S., A. Sridhar, and M. Sivaprakasam, Complete heart block following transcatheter closure of perimembranous VSD using amplatzer duct occluder II. Catheter Cardiovasc Interv, 2017.
9. Carminati, M., et al., Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J, 2007. 28(19): p. 2361-8.